Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
Renal osteodystrophy (ROD) is a complex and serious complication of chronic kidney disease (CKD), a major global health problem caused by loss of renal function. Currently, the gold standard to accurately diagnose ROD is based on quantitative histomorphometric analysis of trabecular bone. Although t...
Main Authors: | Yentl Huybrechts, Pieter Evenepoel, Mathias Haarhaus, Etienne Cavalier, Geert Dams, Wim Van Hul, Patrick C. D’Haese, Anja Verhulst |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/3/598 |
Similar Items
-
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
by: Zengxin Jiang, et al.
Published: (2023-03-01) -
Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
by: Wen Liu, et al.
Published: (2019-05-01) -
Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin
by: Helen J. Knowles, et al.
Published: (2023-05-01) -
Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
by: Marciana Laster, et al.
Published: (2023-09-01) -
Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
by: Jialiang S. Wang, et al.
Published: (2021-03-01)